CROs/Service Providers

Debiopharm, TCG Lifesciences collaborate to develop antibiotics

Monday, September 9, 2013 03:51 PM

Debiopharm Group, a Swiss-based global biopharmaceutical company focused on development of prescription drugs that target unmet medical needs and companion diagnostics, and TCG Lifesciences, a CRO in early drug discovery and development, have inked an exclusive discovery collaboration to develop antibiotics targeting drug-resistant bacteria for community hospital-acquired infections.

More... »

BioReliance opens U.S. clearance services laboratories

Monday, September 9, 2013 12:08 PM

Sigma-Aldrich BioReliance, the biologics and early-development services business under SAFC, has opened a new clearance services facility in Rockville, Md.

More... »

Oncodesign, Banook Central Imaging partner in pharmaco-imaging

Monday, September 9, 2013 12:00 PM

Oncodesign,a CRO  specializing in discovery of new anticancer therapies, and Banook Central Imaging, specializing in the centralized reading of medical images, have partnered to expand the use of new approaches in pharmaco-imaging.

More... »

MicroConstants China in-licenses liver cancer drug from Pertinax Therapeutics

Monday, September 9, 2013 11:54 AM

Site management organization and CRO MicroConstants China will in-license the China rights for a phase II liver cancer drug, PTX-9908, from Pertinax Therapeutics of Canada. MicroConstants China will be responsible for funding clinical development of PTX-9908 in China. Pertinax will receive a royalty in connection with sales, as well as any future assignment or transfer of the rights.

More... »

The Clinical Trial Company opens new California office

Friday, September 6, 2013 02:56 PM

The Clinical Trial Company (TCTC), headquartered in the U.K., has incorporated a new U.S. business to meet the growing number of U.S. clients and sponsors, in the San Francisco Bay area.

More... »

Ximedica, Theorem collaborate

Friday, September 6, 2013 02:44 PM

Global CRO Theorem Clinical Research is collaborating with Ximedica, a medical product development firm.

More... »

Covance, Indiana CTSI collaborate

Wednesday, September 4, 2013 12:28 PM

CRO Covance and the Indiana Clinical and Translational Sciences Institute (CTSI), part of the Indiana University (IU) School of Medicine, will collaborate to conduct early clinical trials for new medicines. 

More... »

PSI opens Italian office

Wednesday, August 28, 2013 12:34 PM

Global CRO PSI opened an operational office in Italy, expanding its presence in Europe and strengthening its ability to deliver global clinical trials. The office is located outside Milan.

More... »

PPD acquires Acurian

Tuesday, August 27, 2013 10:20 AM

Wilmington, N.C.-based CRO Pharmaceutical Product Development (PPD) has acquired Acurian, a provider of clinical trial patient enrollment and retention solutions for the life sciences industry. 

More... »

Cresset expands scientific team, relocates to Cambridge Cluster

Monday, August 26, 2013 12:19 PM

Cresset, a provider of chemistry software and services, has relocated near Cambridge Cluster, in Litlington, Cambridgeshire, which will serve as the company's global headquarters.

More... »